This statistic displays the frequency of amphetamines use in the last month in countries of the European Union in 2022. Amphetamines are a group of synthetic psychoactive drugs which are often used recreationally. Among treatment entrants, 28 percent used amphetamines daily in the last month, while 14 percent of them used amphetamines four to six days a week.

The Netherlands had the highest prevalence of ecstasy use among adults in Europe as of 2022, with approximately five percent of the population reported to using ecstasy. This was followed by Ireland with 2.7 percent of the population and then Czechia at 1.9 percent. Demographics of users in the Netherlands Among the younger age groups is where both frequent and infrequent users of ecstasy are found in the Netherlands. Almost 30 percent of those aged between 25 and 29 years have tried ecstasy at some point in their lives, as of a 2021 survey. While almost four percent in the same age group stated they had taken ecstasy in the past month. Use of other drugs in the EU Cannabis is by far the most used drug across the population of the European Union, with almost 30 using at some point during their lifetime. This is followed by cocaine, which reportedly five percent have used in their life and then MDMA with four percent of individuals having used. Additionally, cannabis was the most seized drug in Europe in 2021, with 77 percent of all seizures being a form of cannabis.

In Latvia in 2022, 18.7 people per million population (pmp) were diagnosed with HIV as a result of injecting drug use, this was the highest rate of any European country. HIV can spread among drug users due to sharing of needles, syringes and other such injecting equipment. Luxembourg had the second-highest incidence of HIV due to drug use at 18.6 diagnoses pmp, and then Lithuania at 11.4 cases of HIV pmp.

In 2022, the European country with the highest number of individuals in substitution treatment for opioid addiction was France, with over 177 thousand individuals. While in Germany, approximately 81 thousand individuals were in substitution treatment.